A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis

Original Article

R.J. Nowak, M. Benatar, E. Ciafaloni, J.F.H. Jr., Jr., M.I. Leite, K. Utsugisawa, J. Vissing, M. Rojavin, Q. Li, F. Tang, Y. Wu, N. Rampal, and S. Cheng

N Engl J Med 2025;392:2309-2320

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
06/18/2025
Course expires: 
06/19/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.